vs
Side-by-side financial comparison of Legacy Housing Corp (LEGH) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
Legacy Housing Corp is the larger business by last-quarter revenue ($25.5M vs $18.3M, roughly 1.4× ROCKWELL MEDICAL, INC.). Legacy Housing Corp runs the higher net margin — 32.2% vs -3.0%, a 35.2% gap on every dollar of revenue. On growth, ROCKWELL MEDICAL, INC. posted the faster year-over-year revenue change (-25.6% vs -30.6%). Legacy Housing Corp produced more free cash flow last quarter ($15.7M vs $2.2M). Over the past eight quarters, Legacy Housing Corp's revenue compounded faster (-9.1% CAGR vs -10.1%).
Legacy Housing Corp is a prominent U.S.-based manufacturer of affordable manufactured homes, tiny homes, and accessory dwelling units. It mainly caters to low- and middle-income consumers across North America, providing customizable residential solutions, supporting construction materials, and after-sales services for individual and community development clients.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
LEGH vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $25.5M | $18.3M |
| Net Profit | $8.2M | $-554.0K |
| Gross Margin | 26.4% | 21.1% |
| Operating Margin | 40.4% | -2.2% |
| Net Margin | 32.2% | -3.0% |
| Revenue YoY | -30.6% | -25.6% |
| Net Profit YoY | -43.5% | 26.7% |
| EPS (diluted) | $0.38 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $25.5M | $18.3M | ||
| Q3 25 | $28.8M | $15.9M | ||
| Q2 25 | $38.4M | $16.1M | ||
| Q1 25 | $24.3M | $18.9M | ||
| Q4 24 | $36.7M | $24.7M | ||
| Q3 24 | $30.2M | $28.3M | ||
| Q2 24 | $31.7M | $25.8M | ||
| Q1 24 | $30.8M | $22.7M |
| Q4 25 | $8.2M | $-554.0K | ||
| Q3 25 | $8.6M | $-1.8M | ||
| Q2 25 | $14.7M | $-1.5M | ||
| Q1 25 | $10.3M | $-1.5M | ||
| Q4 24 | $14.5M | $-756.0K | ||
| Q3 24 | $15.8M | $1.7M | ||
| Q2 24 | $16.2M | $343.0K | ||
| Q1 24 | $15.1M | $-1.7M |
| Q4 25 | 26.4% | 21.1% | ||
| Q3 25 | 20.2% | 14.3% | ||
| Q2 25 | 32.4% | 15.6% | ||
| Q1 25 | 29.2% | 16.1% | ||
| Q4 24 | 27.3% | 14.7% | ||
| Q3 24 | 29.2% | 22.0% | ||
| Q2 24 | 31.9% | 17.6% | ||
| Q1 24 | 33.6% | 13.5% |
| Q4 25 | 40.4% | -2.2% | ||
| Q3 25 | 33.7% | -9.9% | ||
| Q2 25 | 43.8% | -8.4% | ||
| Q1 25 | 47.7% | -7.2% | ||
| Q4 24 | 42.3% | -2.1% | ||
| Q3 24 | 50.8% | 6.8% | ||
| Q2 24 | 50.6% | 2.0% | ||
| Q1 24 | 54.3% | -5.8% |
| Q4 25 | 32.2% | -3.0% | ||
| Q3 25 | 30.0% | -11.0% | ||
| Q2 25 | 38.3% | -9.3% | ||
| Q1 25 | 42.3% | -8.0% | ||
| Q4 24 | 39.5% | -3.1% | ||
| Q3 24 | 52.4% | 5.9% | ||
| Q2 24 | 51.1% | 1.3% | ||
| Q1 24 | 49.1% | -7.6% |
| Q4 25 | $0.38 | $-0.01 | ||
| Q3 25 | $0.35 | $-0.05 | ||
| Q2 25 | $0.60 | $-0.05 | ||
| Q1 25 | $0.41 | $-0.04 | ||
| Q4 24 | $0.59 | $-0.02 | ||
| Q3 24 | $0.64 | $0.04 | ||
| Q2 24 | $0.65 | $0.01 | ||
| Q1 24 | $0.60 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.5M | $10.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $528.6M | $37.0M |
| Total Assets | $580.3M | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.5M | $10.7M | ||
| Q3 25 | $13.6M | $13.6M | ||
| Q2 25 | $2.6M | $12.5M | ||
| Q1 25 | $3.4M | $11.4M | ||
| Q4 24 | $1.1M | $15.7M | ||
| Q3 24 | $570.0K | $12.3M | ||
| Q2 24 | $60.0K | $11.9M | ||
| Q1 24 | $621.0K | $6.6M |
| Q4 25 | $528.6M | $37.0M | ||
| Q3 25 | $521.6M | $37.0M | ||
| Q2 25 | $512.8M | $30.4M | ||
| Q1 25 | $503.7M | $31.5M | ||
| Q4 24 | $494.0M | $32.6M | ||
| Q3 24 | $479.3M | $29.1M | ||
| Q2 24 | $463.2M | $23.5M | ||
| Q1 24 | $450.4M | $20.6M |
| Q4 25 | $580.3M | $57.1M | ||
| Q3 25 | $557.9M | $57.5M | ||
| Q2 25 | $552.0M | $52.6M | ||
| Q1 25 | $544.6M | $54.0M | ||
| Q4 24 | $534.2M | $59.2M | ||
| Q3 24 | $521.4M | $57.1M | ||
| Q2 24 | $514.9M | $53.0M | ||
| Q1 24 | $510.0M | $50.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $19.0M | $2.3M |
| Free Cash FlowOCF − Capex | $15.7M | $2.2M |
| FCF MarginFCF / Revenue | 61.6% | 12.0% |
| Capex IntensityCapex / Revenue | 13.1% | 0.5% |
| Cash ConversionOCF / Net Profit | 2.32× | — |
| TTM Free Cash FlowTrailing 4 quarters | $28.2M | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.0M | $2.3M | ||
| Q3 25 | $7.2M | $-1.3M | ||
| Q2 25 | $6.1M | $1.8M | ||
| Q1 25 | $4.9M | $-3.5M | ||
| Q4 24 | $7.9M | $865.0K | ||
| Q3 24 | $13.8M | $4.3M | ||
| Q2 24 | $3.5M | $1.4M | ||
| Q1 24 | $10.8M | $-2.4M |
| Q4 25 | $15.7M | $2.2M | ||
| Q3 25 | $5.1M | $-1.5M | ||
| Q2 25 | $3.7M | $1.7M | ||
| Q1 25 | $3.6M | $-3.5M | ||
| Q4 24 | $6.0M | $470.0K | ||
| Q3 24 | $9.1M | $4.1M | ||
| Q2 24 | $1.7M | $1.2M | ||
| Q1 24 | $9.9M | $-2.5M |
| Q4 25 | 61.6% | 12.0% | ||
| Q3 25 | 17.8% | -9.6% | ||
| Q2 25 | 9.6% | 10.5% | ||
| Q1 25 | 15.0% | -18.8% | ||
| Q4 24 | 16.4% | 1.9% | ||
| Q3 24 | 30.2% | 14.4% | ||
| Q2 24 | 5.4% | 4.5% | ||
| Q1 24 | 32.2% | -11.1% |
| Q4 25 | 13.1% | 0.5% | ||
| Q3 25 | 7.1% | 1.4% | ||
| Q2 25 | 6.2% | 1.0% | ||
| Q1 25 | 5.2% | 0.3% | ||
| Q4 24 | 5.1% | 1.6% | ||
| Q3 24 | 15.6% | 0.7% | ||
| Q2 24 | 5.5% | 1.1% | ||
| Q1 24 | 2.8% | 0.6% |
| Q4 25 | 2.32× | — | ||
| Q3 25 | 0.83× | — | ||
| Q2 25 | 0.41× | — | ||
| Q1 25 | 0.48× | — | ||
| Q4 24 | 0.54× | — | ||
| Q3 24 | 0.88× | 2.57× | ||
| Q2 24 | 0.21× | 4.20× | ||
| Q1 24 | 0.71× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LEGH
| Commercial Sales | $8.6M | 34% |
| Retail Store Sales | $6.0M | 24% |
| Inventory Finance Sales | $5.0M | 20% |
| Direct Sales | $4.4M | 17% |
| Other | $1.5M | 6% |
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
